Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-058927
Filing Date
2008-03-17
Accepted
2008-03-17 16:46:09
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1100338
2 OFFICE LEASE, BY AND BETWEEN KASHIWA FUDOSAN AMERICA, INC. AND NOVACEA, INC. dex1010.htm EX-10.10 524085
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1614
4 CERTIFICATION OF THE COMPANY'S CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9004
5 CERTIFICATION OF THE COMPANY'S CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9010
6 CERTIFICATION OF THE COMPANY'S CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 2537
7 CERTIFICATION OF THE COMPANY'S CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 2557
8 GRAPHIC g14374g68r58.jpg GRAPHIC 58841
9 GRAPHIC g14374g99a25.jpg GRAPHIC 25757
10 GRAPHIC g14374newpg57.jpg GRAPHIC 239719
11 GRAPHIC g14374plan_tx56.jpg GRAPHIC 303104
  Complete submission text file 0001193125-08-058927.txt   2515660
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 200 SOUTH SAN FRANCISCO CA 94025-1918
Business Address 400 OYSTER POINT BOULEVARD SUITE 200 SOUTH SAN FRANCISCO CA 94025-1918 (650) 228-1800
NOVACEA INC (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51967 | Film No.: 08693464
SIC: 2834 Pharmaceutical Preparations